ACS CAN comments opposing DEA's proposal to reschedule hydrocodone combination products April, 2014

April 28, 2014

In response to a proposal to reschedule certain pain medications, ACS CAN offered comments expressing concern over the effects of the action on the ability for cancer patients to access needed treatment for their pain.